Retatrutide is a novel investigational medicine currently in clinical development
No office visits, no scheduling around a provider's availability
Here's what researchers consistently miss: both protocols elevate GH, but only one does it the way your body evolved to handle it
Its small-molecule candidate danuglipron showed promising efficacy, with placebo-adjusted weight reductions of 813% in Phase 2b trials
"When patients are losing weight, especially quickly or while on GLP-1 medications, I often see nutrient deficiencies that first show up in the skin, hair and nails," says Dr
Ozempic (semaglutide GLP-1) is a well-known GLP-1 medication that helps reduce appetite and promote weight loss by acting on these hunger-regulating pathways